CoChat

Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus

Open access

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index; 39 of the 68 sources its claims cite were checked for support.

Abstract

BACKGROUND: The common recommendation for hypoglycemia treatment, oral ingestion of 15 g of simple carbohydrates and glucose recheck in 15 min, was predominantly based on expert opinion, and two small-sized studies of intravenous insulin-induced hypoglycemia in people living with type 1 diabetes mellitus (T1D). The evidence for "15 grams/15 minutes" treatment for people living with type 2 diabetes mellitus (T2D) needs to be explored. The objective of this systematic review is to determine which oral carbohydrate treatments were studied in adults living with T2D for timely resolution of hypoglycemia events. METHODS: Medline, Embase, Scopus, and Cochrane Central Register of Controlled Trials were searched from January 1990 to 24 March 2025, for full-text studies of oral treatment for hypoglycemia in T2D. Two authors screened the results and extracted data. Inclusion criteria included age > = 18 years with T2D, treated with a defined quantity of simple carbohydrates, and reported hypoglycemia event resolution as a defined time of first glucose recheck after treatment completion. Exclusion criteria included non-oral route of hypoglycemia treatment. The Newcastle-Ottawa scale was used for risk of bias assessment. RESULTS: Three studies were included, which reported on 152 insulin-treated adults who experienced 366 hypoglycemia events. None of these three studies presented if the participants were or were not on sulfonylurea concurrently, nor did they present a breakdown of the types of insulin(s) (long-acting versus rapid-acting) for the participants. All studies had different oral hypoglycemia treatments and various glucose recheck times. Hence, data synthesis was not possible. There was near 100% hypoglycemia resolution with 15 g carbohydrates at 30-minute recheck in a study of mild hypoglycemia in hospitalized people living with type 2 diabetes. An at-home study showed 95% hypoglycemia resolution with 30 g carbohydrates at 10-minute recheck, although rebound hyperglycemia became a concern. The studies had low risk of bias. CONCLUSION: Three studies provided a very limited evidence base for hypoglycemia treatment in T2D. Future studies are encouraged to identify and analyze people living with T2D who are treated with sulfonylurea, with or without insulin therapy, to reflect hypoglycemia treatment over the breadth of T2D pharmacotherapy. CLINICAL TRIAL NUMBER: Not applicable. TRIAL REGISTRATION: Prospero registration number CRD420251032322. No amendments. Study protocol can be obtained by sending a written request to the corresponding author.

Overview

CoChat Summary

## TL;DR

This systematic review found only 3 small studies on oral carbohydrate treatment for hypoglycemia in adults with type 2 diabetes, covering 152 insulin-treated adults and 366 hypoglycemia events. The evidence base was too limited and heterogeneous to support a firm “15 g / 15 min” recommendation for T2D.

## Key findings

  • 3 studies met inclusion criteria; together they reported 152 insulin-treated adults and 366 hypoglycemia events.
  • The studies used different carbohydrate sources/amounts and different glucose recheck times, so data synthesis was not possible.
  • One inpatient T2D study found near 100% hypoglycemia resolution with 15 g carbohydrates at 30 minutes; an at-home study found 95% resolution with 30 g carbohydrates at 10 minutes.
  • The at-home study also reported rebound hyperglycemia in 62% and 63% of events treated with 30 g carbohydrates and 0.3 g/kg, respectively, using a rebound threshold of ≥ 8 mmol/L.

## Methods

  • Design: Systematic review, registered on PROSPERO (CRD420251032322), searching MEDLINE, Embase, Scopus, and Cochrane Central from January 1990 to 24 March 2025.
  • Sample/data: Included full-text English or French studies of adults (≥18 years) with T2D given a defined quantity of simple carbohydrates for hypoglycemia; non-oral treatment was excluded.
  • Analysis: Two authors independently screened/extracted data and assessed risk of bias with the Newcastle-Ottawa scale; synthesis was only planned when studies matched on carbohydrate type/amount and recheck time, but this was not achievable.

## Limitations

  • The paper states that the evidence was very limited, with only 3 small-sized studies; one study did not distinguish T2D from T1D, limiting certainty.
  • The studies did not report whether participants were taking sulfonylureas or provide a breakdown of long-acting vs rapid-acting insulin.
  • Evidence from one study was of limited applicability because it used a very low hypoglycemia resolution threshold (<3.5 mmol/L), which the authors note is below common guideline thresholds of 3.9 or 4.0 mmol/L.
  • Evident from the text: the review searched only English/French full texts and published literature, so it may have missed abstract-only, non-English, or unpublished studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12902-025-02144-3

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Literature search and screening flow diagram [9, 10]
Fig. 1 Literature search and screening flow diagram [9, 10]CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

23 Valid · 0 Not valid · 5 Not checked · 26 Own results and interpretations

19 more claims · 4 with their cited sources checked

Create a free account to see all 54 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Citations

Cites

Show all 25 references

Research works printed but not linked: 1

  1. Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000‑. Updated 30 Dec 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279093/

Metadata

Authors
Prince, N., Lochnan, H., Shorr, R., Garon-Mailer, A., & Sun, C. J.
Affiliations
  • University of Ottawa (CA)
  • Ottawa Hospital (CA)
Corresponding author
Sun, Cathy J.
Venue
BMC Endocrine Disorders
Published
2026-01-22
Volume
26
Issue
1
Pages
50-50
ISSN
1472-6823 (ISSN-L)
OpenAlex
W7125510268
Cited by
0
References
26
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Endocrine Disorders (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
hypoglycemia, type 2 diabetes, monosaccharides, insulin-treated diabetes, sulfonylureas, rebound hyperglycemia, hospitalized patients, rapid-acting insulin
MeSH terms
Administration, Oral, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Carbohydrates, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1186/s12902-025-02144-3
The paper
Prince, N., Lochnan, H., Shorr, R., Garon-Mailer, A., & Sun, C. J. (2026). Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-025-02144-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.